Startup Professionals Musings

OCTOBER 20, 2014

But I continue to learn that there are a host of other factors, maybe not even related to you or your business, that could keep you from getting the funding that you need. The good news is that both of these are looking up these days. Almost 80% of the funding handed out in the US consistently comes from these three locations.

Funding 108

Funding Entrepreneur Venture Capital Startup 108

Xconomy

JULY 15, 2016

And then the news flowed, from a fast reprieve for Juno Therapeutics to no mercy for Elizabeth Holmes. After last week’s revelation of three patient deaths in its leading cancer immunotherapy trial, the FDA suspended the study. —Enough good trial news. million in funding, according to a regulatory filing.

News 40

News Technical Review San Diego Startup 40

Startup Professionals Musings

JULY 14, 2014

The “valley of death” is a common term in the startup world, referring to the difficulty of covering the negative cash flow in the early stages of a startup, before their new product or service is bringing in revenue from real customers. Solicit funds from friends and family. Use crowd funding. Set expectations accordingly.

Entrepreneur 113

Entrepreneur Funding Startup Technical Review 113

Xconomy

AUGUST 11, 2016

government has ambitious plans for a long-term health study with one million Americans, and one of the world’s most powerful tech companies has a big part to play, including the storage of all the data on its “cloud” servers. ” Verily’s role has since shifted, however. Vanderbilt had a head start stumping for it.

PMI 40

PMI Study Google Research 40

Xconomy

DECEMBER 21, 2018

It’s beginning to look a lot like, well, the last roundup of the year, with plenty of news to pack in before our holiday breather.

Pricing 73

Pricing Sales Study News 73

socalTECH

MAY 8, 2017

The company is backed by more than $67M in funding from such investors as Glynn Capital Management, GV (formerly Google Ventures), Amgen Ventures, Lux Capital, Redmile Group, dRx Capital (a Qualcomm and Novartis joint investment company), and Sanofi Ventures. Belinda Tan: Most of our trials are Phase 2 and Phase 3 studies.

Technology 133

Technology Study UCLA Research 133

socalTECH

JULY 20, 2011

Earlier this month, Los Angeles-based HitFix (www.hitfix.com) an online news site focused on entertainment, announced it had raised $2M in a funding round. We spoke with Jennifer about what HitFix is looking to do, her own background, and how HitFix is different from the many celebrity gossip and news sites out there.

News 173

News Entertainment Startup Bertelsmann 173

Xconomy

NOVEMBER 7, 2016

Up until this point, studies of an experimental drug from Biogen and Ionis Pharmaceuticals had focused on patients with the most severe form of a rare, potentially deadly genetic disorder called spinal muscular atrophy. But new data released this morning show that the therapy, known as nusinersen (Spinraza), could have a much broader reach.

Help 97

Help Study Research Statistics 97

socalTECH

APRIL 12, 2013

There''s been a lot of activity over the past two years in the Southern California accelerator/incubator market, with numerous groups (Amplify, EvoNexus, K5, LaunchpadLA, MediaCamp, Science, StartEngine, and many, many others) looking to help entrepreneurs start and fund their companies. where we totalled up $33.85M in funding.

Southern California 222

Southern California Incubator Report Startup 222

socalTECH

DECEMBER 30, 2016

What's the biggest news from you or your‏ firm this year? Rob Freelen: The best lesson I learned in 2016 is that a well-managed company can succeed in any funding environment. I studied East Asian religions in college and was intrigued to hear that a Buddhist monk was delivering meditation and mindfulness via a mobile app.

Santa Monica 124

Santa Monica Southern California Venture Capital SoCalTech 124

Xconomy

MARCH 22, 2019

One group of people in dire need of medical relief got good news this week. We reported on both those stories and a lot more, including clinical ups and downs and new fundings. The first drug for postpartum depression was approved. women giving birth. But at least it’s an option. Also this week: Reports from.

Help 59

Help News Report Funding 59

socalTECH

DECEMBER 27, 2018

What was the biggest news for your company in 2018? When I first joined Crosscut Ventures five years ago, the firm had $20 million under management and was just starting to invest out of its second fund. We now have $250 million under management, are investing out of our fourth fund and have made more than 80 investments.

Riot Games 133

Riot Games Southern California Startup Santa Monica 133

socalTECH

MARCH 2, 2016

The reason why, was one of our angel investors was a big news and political junky, and he was also the biggest angel in Opposing Views. million in funding, but ended up burning through it. On the news side, we're non partisan, which has led to lots more growth, as we tend to appeal to everyone, which has helped a lot too.

Media 100

Media Content News SEO 100

socalTECH

JANUARY 3, 2019

What was the biggest news for your company in 2018? 2018 was a great year for TVC Capital and we were able to get our fourth growth equity fund closed, taking our assets under management to close to $400 million. Lexus studied customers in the US and predicted that car buyers had just had it with clunky US cars. I doubt it.

Capital 113

Capital Southern California El Segundo SaaS 113

Xconomy

OCTOBER 7, 2016

. —Alnylam Pharmaceuticals (NASDAQ: ALNY ) of Cambridge, MA, said that it would shelve its drug revusiran after 18 patients died in a Phase 3 study to treat the rare disease transthyretin amyloidosis. The funding could be as much as $100 million, and the first grants will be announced in 2017. CLINICAL NEWS.

Technical Review 77

Technical Review Study Layoffs San Diego 77

Both Sides of the Table

SEPTEMBER 21, 2016

The news blogs will cover the what, how and how much but I want to focus on the “why” and try to be instructive of what I think makes for a great A-round startup. I speak a lot on college campuses and entrepreneur events and amongst the most common things I’m asked to talk about are: What do VCs fund?

Design 150

Design Ideas Startup Writing 150

Xconomy

JULY 8, 2016

But the news in our little corner of the world doesn’t stop. Mergers—or threats thereof—deals, fundings, and all kinds of data keep on keeping on. Congress will come to terms on a package of healthcare reforms and funding known as 21st Century Cures. —Another health scourge was in the news: hepatitis.

Pricing 52

Pricing News Journal Startup 52

Startup Professionals Musings

JULY 8, 2015

The “valley of death” is a common term in the startup world, referring to the difficulty of covering the negative cash flow in the early stages of a startup, before their new product or service is bringing in revenue from real customers. Solicit funds from friends and family. Use crowd funding to build reserves.

Entrepreneur 105

Entrepreneur Startup Technical Review Equity 105

Startup Professionals Musings

FEBRUARY 19, 2013

The “valley of death” is a common term in the startup world, referring to the difficulty of covering the negative cash flow in the early stages of a startup, before their new product or service is bringing in revenue from real customers. Solicit funds from friends and family. Use crowd funding. Set expectations accordingly.

Startup 123

Startup Technical Review Equity Incubator 123

Both Sides of the Table

AUGUST 12, 2010

We led off with a discussion about Slide being acquired by Google, which was breaking news in the time slot where we filmed this episode. People like Fred Wilson who say let all the small companies fund and bloom, create more jobs, etc. A recent study said seed stage valuations have been quite static recently. Minutes 8 – 10.

Venture Capital 232

Venture Capital Slides Seed Funding Google 232

socalTECH

OCTOBER 1, 2008

A study of the venture capital deal flow in Southern California conducted by socalTECH shows that venture capital deals dropped for Q3, to around $720M in deals, in a market dominated by clean technology firms. in venture capital deals in the third quarter, down dramatically from $1.2B

Southern California 100

Southern California SoCalTech Technical Review Draper 100

socalTECH

DECEMBER 30, 2015

Today, we have the thoughts of Jeb Spencer of TVC Capital (www.tvccapital.com), a software focused growth equity fund which just raised a new fund, and has had some great success in the market. What was the biggest news for you or your firm this year? TVC Capital has also been a big supporter of socaltech over the years.

Capital 100

Capital Beverly Hills Artificial Inteligence Equity 100

Xconomy

DECEMBER 5, 2018

Let’s get caught up with the latest life sciences news in San Diego. Even as all eyes were on the American Society of Hematology (ASH) conference in downtown San Diego this week, other biotech companies were staying busy.

San Diego 79

San Diego Conference News Develop 79

socalTECH

AUGUST 2, 2013

Yapert raised a funding round a few weeks ago from the Tech Coast Angels, Desert Angeles, and Pasadena Angels for its mobile apps, which consolidates news and information about your favorite interests. We really started to study the current generation of smartphones and what people do with them. How did the company start?

Mobile 159

Mobile Startup Entertainment Tech Coast Angels 159

Startup Professionals Musings

JULY 1, 2017

According to my experience and a classic Gompers and Lerner study, the challenge is very real, with a majority of new ventures that don't attract investors failing within the first three years. Self-funding or bootstrapping is still the most common and safest approach for startups Keep your day job until revenue starts to flow.

Develop 70

Develop Development Product Startup 70

Startup Professionals Musings

APRIL 24, 2013

But I continue to learn that there are a host of other factors, maybe not even related to you or your business, that could keep you from getting the funding that you need. The good news is that both of these are looking up these days. Almost 80% of the funding handed out in the US consistently comes from these three locations.

Venture Capital 95

Venture Capital Capital Startup Funding 95

Eric Greenspan

JUNE 25, 2015

Three years ago, I got the news that my investor was unable to fund and my 11 year old company would miss it’s first payroll. When the news arrived, I moved fast and did all I could to start the process of acceptance. It was a Sunday, around noon. Since, I have not.

News 100

News Startup Study Google 100

Xconomy

AUGUST 8, 2016

After reporting encouraging news last week from a mid-stage trial of its lead anti-cancer drug, San Diego’s MEI Pharma (NASDAQ: MEIP ) said it has signed a drug development deal with the Swiss pharmaceutical group Helsinn that could eventually be worth over $464 million. months in previously untreated elderly patients who received the drug.

Study 40

Study San Diego News Design 40

Xconomy

JULY 29, 2016

Amongst several companies to report this week, the biggest news came from Gilead Sciences (NASDAQ: GILD ), whose hepatitis C drugs have become some of the top revenue producers in the industry. The study is one of several Celgene is running to try to expand the use of its blockbuster blood cancer drug. government and the U.K.’s

Startup 40

Startup Study News Report 40

Both Sides of the Table

JANUARY 29, 2013

And it was the first word I muttered when I heard the news tonight. I don’t think we can fund in that category, Jody. How smart she was – studying to be a doctor. We still had so many more times to spend together. I loved this image I saw posted by Andy Rankin. I remember when we met years ago. No, seriously.

Venture Capital 406

Venture Capital Study Writing News 406

Xconomy

FEBRUARY 24, 2017

As we’ve come to expect, however, there was no dearth of health and life-sciences news from Washington, D.C.

Sales 49

Sales News Funding Artificial Inteligence 49

Xconomy

JUNE 24, 2016

The FDA still has to clear the study, but if it does, it’s sure to become one of the most closely watched scientific events in more than a decade. There’s plenty more news to chew on as well, from the latest developments in the Zika battle to biotech’s sigh of relief when Medicare spending cuts were avoided (for now). .

Research 59

Research IBM IBM Artificial Inteligence 59

socalTECH

DECEMBER 5, 2012

I always said--how much better would life be if I could sit at a table of locals, eat, and talk about our commonalities, and get local insider news. The thing about SupperKing, is you get to meet new people and interact with them, build new friendships, and it's not just about monetization. What were you doing before?

Platform 250

Platform Mobile UCLA Sites 250

socalTECH

DECEMBER 5, 2012

I always said--how much better would life be if I could sit at a table of locals, eat, and talk about our commonalities, and get local insider news. The thing about SupperKing, is you get to meet new people and interact with them, build new friendships, and it's not just about monetization. What were you doing before?

Platform 247

Platform Mobile UCLA Sites 247

Both Sides of the Table

FEBRUARY 27, 2010

There have been many studies done on the topic including looking at twins raised in separate families. There have been studies of adopted children to their natural parents versus the parents that raised them. I have also seen studies on “birth order.&#. I’m now a VC that funds entrepreneurs.

Startup 289

Startup Statistics Entrepreneur Study 289

Xconomy

AUGUST 2, 2016

Officials at USA Football had to concede that they did not review the data from the study carefully and did not realize that the positive data they were publicizing contradicted data from the same study published one year ago that showed negative results for the Heads Up Football program. He has no financial interests to disclose.

Study 40

Study Training News Statistics 40

Xconomy

JUNE 17, 2016

Familiar biotech names—not necessarily familiar for the right reasons—made news this week in biotech. —News for a group of slumping East Coast biotechs: Christoph Westphal and former Genzyme CEO Henri Termeer both stepped down from the board of Cambridge-based Verastem (NASDAQ: VSTM ), whose shares are worth just over $1.30

News 55

News Technical Review Conference Report 55